• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    bioAffinity Technologies, Inc. - Common Stock (NQ: BIAF )

    2.435 +0.065 (+2.74%)
    Streaming Delayed Price Updated: 1:40 PM EDT, May 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about bioAffinity Technologies, Inc. - Common Stock

    < Previous 1 2 3 4 Next >
    BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q1 2024
    bioAffinity Technologies just reported results for the first quarter of 2024. 
    Via InvestorPlace
    bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
    From bioAffinity Technologies, Inc.
    Via Business Wire
    bioAffinity Technologies News Update
    From bioAffinity Technologies, Inc.
    Via Business Wire
    bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
    From bioAffinity Technologies, Inc.
    Via Business Wire
    bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
    From bioAffinity Technologies, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q4 2023
    bioAffinity Technologies just reported results for the fourth quarter of 2023. 
    Via InvestorPlace
    bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
    From bioAffinity Technologies, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart... 
    Via Benzinga
    Exposures Product Safety
    bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
    From bioAffinity Technologies, Inc.
    Via Business Wire
    Nasdaq Gains 100 Points; Campbell Soup Earnings Top Views
    U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Wednesday. The Dow traded up 0.20% to 38,662.69 while the NASDAQ rose 0.64% to 16,041.08. The... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results. 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why BioAffinity Technologies (BIAF) Shares Are Down 50%
    BioAffinity Technologies shares are trading lower by 50.7% during Wednesday's session. The company announced a securities purchase agreement with institutional investors. 
    Via Benzinga
    bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
    From bioAffinity Technologies, Inc.
    Via Business Wire
    bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung
    From bioAffinity Technologies, Inc.
    Via Business Wire
    Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. 
    Via Benzinga
    bioAffinity Technologies News Update
    From bioAffinity Technologies, Inc.
    Via Business Wire
    Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice
    From bioAffinity Technologies, Inc.
    Via Business Wire
    bioAffinity Technologies In The News
    From bioAffinity Technologies, Inc.
    Via Business Wire
    bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer
    From bioAffinity Technologies
    Via Business Wire
    bioAffinity Technologies In the News
    From bioAffinity Technologies
    Via Business Wire
    bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
    Via ACCESSWIRE
    Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy... 
    Via Benzinga
    bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors
    From bioAffinity Technologies, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024
    From bioAffinity Technologies, Inc.
    Via Business Wire
    bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post
    From bioAffinity Technologies, Inc.
    Via Business Wire
    bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening
    From bioAffinity Technologies, Inc.
    Via Business Wire
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.